Stem Cell Reviews and Reports
ISSN 2629-3269 · Springer Nature · United States · active 2011–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Stem Cell Reviews and Reports a predatory journal?
Our screening does not flag Stem Cell Reviews and Reports. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Stem Cell Reviews and Reports indexed in Scopus or Web of Science?
Per our venue index, Stem Cell Reviews and Reports appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Stem Cell Reviews and Reports's impact?
Papers in Stem Cell Reviews and Reports are cited about 3.5 times each within two years of publication, and Scimago places it in Q2, with an h-index of 57. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Stem Cell Reviews and Reports open access?
We hold no reliable open-access classification for Stem Cell Reviews and Reports. Check the journal's own site for its access model and any article processing charge.